Ratio Analysis: Unpacking Marex Group Plc (MRX)’s Price-to-Cash and Price-to-Free Cash Flow

Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.

After finishing at $35.72 in the prior trading day, Marex Group Plc (NASDAQ: MRX) closed at $36.1, up 1.06%. In other words, the price has increased by $1.06 from its previous closing price. On the day, 1.06 million shares were traded. MRX stock price reached its highest trading level at $36.24 during the session, while it also had its lowest trading level at $35.3.

Ratios:

Our goal is to gain a better understanding of MRX by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 0.20 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 2.23. For the most recent quarter (mrq), Quick Ratio is recorded 1.07 and its Current Ratio is at 1.08. In the meantime, Its Debt-to-Equity ratio is 7.89 whereas as Long-Term Debt/Eq ratio is at 1.94.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, TD Cowen on July 14, 2025, initiated with a Buy rating and assigned the stock a target price of $54.

On March 10, 2025, HSBC Securities Downgraded its rating to Hold which previously was Buy and also upped its target price recommendation from $33 to $36.

On November 21, 2024, HSBC Securities started tracking the stock assigning a Buy rating and target price of $33.HSBC Securities initiated its Buy rating on November 21, 2024, with a $33 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 23 ’25 when Ian Lowitt bought 210,000 shares for $39.14 per share.

Simon Van Den Born bought 56,000 shares of MRX for $2,194,640 on Jun 16 ’25. On Jun 16 ’25, another insider, Nilesh Kumar Jethwa, who serves as the Officer of the company, bought 60,920 shares for $39.19 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRX now has a Market Capitalization of 2631657472 and an Enterprise Value of 1770767232. As of this moment, Marex’s Price-to-Earnings (P/E) ratio for their current fiscal year is 13.28, and their Forward P/E ratio for the next fiscal year is 8.73. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.94. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.89 while its Price-to-Book (P/B) ratio in mrq is 2.55. Its current Enterprise Value per Revenue stands at 0.679.

Stock Price History:

The Beta on a monthly basis for MRX is -0.32, which has changed by 0.4892739 over the last 52 weeks, in comparison to a change of 0.13054323 over the same period for the S&P500. Over the past 52 weeks, MRX has reached a high of $49.34, while it has fallen to a 52-week low of $22.33. The 50-Day Moving Average of the stock is -4.63%, while the 200-Day Moving Average is calculated to be -0.59%.

Shares Statistics:

The stock has traded on average 1.29M shares per day over the past 3-months and 1239660 shares per day over the last 10 days, according to various share statistics. A total of 71.70M shares are outstanding, with a floating share count of 52.91M. Insiders hold about 25.72% of the company’s shares, while institutions hold 71.70% stake in the company. Shares short for MRX as of 1753920000 were 3156149 with a Short Ratio of 2.44, compared to 1751241600 on 2143026. Therefore, it implies a Short% of Shares Outstanding of 3156149 and a Short% of Float of 9.370000000000001.

Dividends & Splits

In the trailing 12 months, MRX’s forward annual dividend rate was 0.43, compared to 0.57 this year. Against a Trailing Annual Dividend Yield of 0.0120380735

Earnings Estimates

The firm’s stock currently is rated by 8.0 analysts. The consensus estimate for the next quarter is $0.91, with high estimates of $1.03 and low estimates of $0.8.

Analysts are recommending an EPS of between $3.92 and $3.63 for the fiscal current year, implying an average EPS of $3.78. EPS for the following year is $4.09, with 9.0 analysts recommending between $4.52 and $3.71.

Revenue Estimates

5 analysts predict $474.79M in revenue for the current quarter. It ranges from a high estimate of $485.91M to a low estimate of $461.74M. As of the current estimate, Marex Group Plc’s year-ago sales were $391.2MFor the next quarter, 5 analysts are estimating revenue of $481.19M. There is a high estimate of $496.03M for the next quarter, whereas the lowest estimate is $460.6M.

A total of 6 analysts have provided revenue estimates for MRX’s current fiscal year. The highest revenue estimate was $1.99B, while the lowest revenue estimate was $1.91B, resulting in an average revenue estimate of $1.93B. In the same quarter a year ago, actual revenue was $1.59BBased on 8 analysts’ estimates, the company’s revenue will be $2.06B in the next fiscal year. The high estimate is $2.28B and the low estimate is $1.86B.

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.